Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Share News (GWP)

  • There is currently no data for GWP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK GDP growth slumps to half previous rate, NIESR data shows

Tue, 09th Aug 2016 12:24

(ShareCast News) - UK economic growth halved in the last three months, according to analysis by a respected independent think tank, which is worse than the market expected and adds credence to predictions that the economy will contract in the third quarter and then fall into recession.Based on its estimates, the National Institute of Economic and Social Research (NIESR) calculated that gross domestic product (GDP) grew by 0.3% in the three months ending in July, down from 6% in the three months to end-June and short of consensus City forecasts for a 0.4% increase.NIESR said the estimate was consistent with its latest quarterly forecast of a 0.2% contraction in the third quarter.The thinktank estimates that there is an even-money chance of a technical recession between the third quarter of 2016 and the final quarter of 2017.James Warren, a research fellow at the institute said this was as marked economic slowdown."The month on month profile, suggests that the third quarter has got off to a weak start, with output declining in July. Our estimates suggest that there is around an evens chance of a technical recession by the end of 2017."The month on month profile suggests output declined in July by 0.2%, though NIESR stressed that monthly calculations are volatile and cautioned against "over-interpreting developments in the fundamentals of the economy from any single month".NIESR uses a model of private services output based on indicator variables so while figures for calendar quarters are fully coherent with ONS data, estimates of monthly private service output are not."The series can be thought of as indicating the underlying value of the ONS series," it said.
More News
28 Apr 2015 07:30

GW Pharma In US Offering Of American Depositary Shares (ALLISS)

Read more
27 Apr 2015 11:09

GW Pharmaceuticals Gets Notice Of Allowance On Cannabidivarin Patent

Read more
23 Apr 2015 07:03

GW Pharmaceuticals Says New Physician Report Data Supports Epidiolex

Read more
21 Apr 2015 11:09

GW Pharmaceuticals Starts Second Phase III Trial For Epidiolex

Read more
14 Apr 2015 12:29

BUZZ-GW Pharmaceuticals Plc: Data on epilepsy drug shows promise

** U.S.-listed shares of London-based maker of cannabis-based drugs up about 9 pct at $104.77 premarket ** Company's childhood epilepsy drug, epidiolex, currently in use through an expanded access program, showed marked improvement in median reduction of seizure frequency, data compiled by

Read more
14 Apr 2015 07:48

GW Pharmaceuticals Says AAN Highlights Epidiolex In New Report

Read more
31 Mar 2015 15:35

BUZZ-U.S. STOCKS ON THE MOVE-Rada Electronic, Intercept Pharma, Alon USA

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks fell on Tuesday in a modest retreat from the previous

Read more
31 Mar 2015 14:00

BUZZ-U.S. STOCKS ON THE MOVE-Lorillard, Charter Communications, Synta Pharma

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks fell at the open on Tuesday, slightly reversing the pr

Read more
31 Mar 2015 13:25

BUZZ-U.S. STOCKS ON THE MOVE-Conn's, Lorillard, GW Pharma, DryShips

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stock were poised to open lower on Tuesday, indicating a mode

Read more
31 Mar 2015 12:27

BUZZ-GW Pharma Plc: Commences trial to test cannabis-based drug in Dravet syndrome

** U.S.-listed shares of the maker of cannabis-based drugs up 4 pct at $91.99 premarket ** The UK-based company has started the second leg of a mid-stage trial testing Epidiolex to treat Dravet syndrome, a rare, treatment-resistant form of childhood epilepsy ** Data from the trial is

Read more
31 Mar 2015 11:21

GW Pharmaceuticals Begins Phase III Epidiolex Trial In Dravet Syndrome

Read more
13 Feb 2015 14:39

UK DIRECTOR DEALINGS SUMMARY: Scholium Team Buys After Profit Warning

Read more
9 Feb 2015 17:35

DIRECTOR DEALINGS: GW Pharmaceuticals COO Sells 10,000 Shares

Read more
5 Feb 2015 08:33

UK MORNING BRIEFING: BT Leads FTSE 100 On EE Deal Confirmation

Read more
5 Feb 2015 06:24

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.